Skip to main content
Aequus Pharmaceuticals Inc. logo

Aequus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · AQS LEI · 54930074SO9K8QF1LJ39 TSXV Manufacturing
Filings indexed 123 across all filing types
Latest filing 2023-08-30 Regulatory Filings
Country CA Canada
Listing TSXV AQS

About Aequus Pharmaceuticals Inc.

https://www.aequuspharma.ca/

Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to developing and commercializing high-quality, differentiated, and value-added products. The company focuses its sales and marketing efforts on highly specialized therapeutic areas, primarily including ophthalmology, neurology, and transplant. Aequus's strategy involves aligning with clinicians, patients, and researchers to address unmet needs within these specialty markets.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-08-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-08-30 English
Interim MD&A - English.pdf
Regulatory Filings
2023-08-30 English
News release - English.pdf
Regulatory Filings
2023-08-22 English
News release - English.pdf
Regulatory Filings
2023-08-18 English
Management information circular - English.pdf
Regulatory Filings
2023-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.